GlassScriptPhysician profile
Ramin Jamm
NPI 1235284266
$4,230.59
in general payments reported to CMS, 2019-2025
21 companies · $541 in 2025
The $541 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $964 · 2020: $506 · 2021: $393 · 2022: $594 · 2023: $416 · 2024: $819 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $848.23 | 2019-2025 | |
| Amgen INC. | $800.52 | 2019-2023 | Evenity, Prolia |
| Radius Health, INC. | $549.00 | 2019-2025 | Tymlos |
| Novo Nordisk INC | $448.78 | 2020-2025 | Wegovy |
| Exeltis, USA INC. | $270.50 | 2024-2025 | Slynd |
| Astellas Pharma US INC | $232.80 | 2024-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.06 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $174.34 | 2020-2025 | |
| Organon LLC | $173.51 | 2022-2024 | |
| Lilly USA, LLC | $109.57 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $99.30 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $64.22 | 2023-2024 | Myfembree |
| Evofem Biosciences, INC. | $41.66 | 2022 | |
| Coopersurgical, INC. | $38.62 | 2019 | |
| Mayne Pharma Commercial LLC | $29.51 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $25.14 | 2025 | The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $23.04 | 2023 | Livalo, Seglentis |
| Myovant Sciences INC. | $22.75 | 2022 | |
| Esperion Therapeutics, INC. | $21.36 | 2023 | Nexletol |
| Ethicon US, LLC | $20.48 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramin Jamm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.